Chemicals · Founded 1980 · www.indoborax.com · BSE 524342 · NSE INDOBORAXC · ISIN INE803D01021
No Notes Added Yet
Business
Indo Borax & Chemicals Ltd. is an Indian chemical manufacturing company primarily engaged in the production of Boron-based chemicals. Its core business revolves around manufacturing products like Borax Decahydrate, Borax Pentahydrate, Boric Acid (Lumps & Powder), and Sodium Perborate Tetrahydrate. These chemicals find applications across various industries, including agriculture (fertilizers, pesticides), ceramics, glass, detergents, pharmaceuticals, fire retardants, and metallurgical fluxes. The company makes money by processing raw borate minerals into value-added boron compounds and selling them to industrial customers domestically and internationally.
Revenue Mix
The company operates predominantly in a single business segment: "Chemicals." Its revenue is primarily generated from the sale of its manufactured boron products. While precise segment-wise revenue contributions are not typically disclosed beyond the overall chemical segment, the major product categories contributing to revenue are:
Boric Acid: Used in glass, ceramics, agriculture, pharmaceuticals, and industrial applications.
Borax (Decahydrate & Pentahydrate): Utilized in detergents, soaps, glass, ceramics, and agriculture.
Sodium Perborate Tetrahydrate: Primarily used as a bleaching agent in detergents.
Industry
Indo Borax & Chemicals operates within the specialty chemicals segment of the broader Indian chemicals industry. The industry for boron-based chemicals in India is relatively niche. The company is one of the established players in the manufacturing of borax and boric acid in India. It competes with imports as well as a few domestic manufacturers. Its positioning is built on its long-standing operational history, manufacturing capabilities, and ability to cater to diverse industrial requirements for boron compounds. The Indian chemicals industry is growing, driven by domestic consumption and a "Make in India" impetus.
MOAT
Indo Borax & Chemicals possesses several potential competitive advantages:
Process Know-how & Experience: Decades of experience in manufacturing boron chemicals have led to optimized production processes and quality control.
Cost Efficiency: Being an established player, the company likely benefits from economies of scale in its niche and optimized operational costs.
Customer Relationships: Long-term relationships with a diverse set of industrial customers across various sectors.
Purity & Quality: In specialty chemicals, consistent product purity and quality are critical, which the company aims to maintain, crucial for sensitive applications like pharmaceuticals.
Growth Drivers
Industrial Growth: Increased demand from end-user industries like ceramics, glass, agriculture, and construction, driven by overall economic growth in India.
Agricultural Demand: Continued growth in the agriculture sector in India, where boron is used as a micronutrient in fertilizers and pesticides.
"Make in India" Initiative: Government focus on boosting domestic manufacturing could reduce reliance on imports and increase demand for locally produced chemicals.
Diversification of Applications: Potential for new applications of boron chemicals in emerging industries or improved formulations.
Export Opportunities: Tapping into global markets for boron chemicals, leveraging cost competitiveness or specific product qualities.
Risks
Raw Material Price Volatility: Borate ores, the primary raw material, are largely imported. Fluctuations in international prices and foreign exchange rates can impact profitability.
Import Competition: Cheaper imports of borax and boric acid can put pressure on domestic prices and margins.
Environmental Regulations: Stringent environmental norms and regulations could necessitate higher compliance costs or restrict operations.
Economic Downturn: A slowdown in key end-user industries (e.g., construction, automotive, agriculture) could reduce demand for the company's products.
Technological Obsolescence/Substitution: While unlikely for basic chemicals, the emergence of alternative materials or processes in end-user industries could affect demand in the long term.
Management & Ownership
Indo Borax & Chemicals is promoted by the Rungta family. Mr. R.L. Rungta serves as the Chairman and Managing Director. The management team has extensive experience in the chemical industry, particularly in the boron chemicals sector, having steered the company for decades. The promoter group holds a significant stake in the company, aligning their interests with long-term shareholder value creation. The ownership structure includes the promoter group and public shareholders.
Outlook
Indo Borax & Chemicals operates in a vital niche of the Indian chemicals industry, benefiting from the consistent demand for boron-based products across diverse sectors. The company's established manufacturing capabilities and long-standing presence provide a stable foundation. Growth prospects are tied to India's overall industrial and agricultural expansion, which could drive demand for its products. However, the company faces inherent risks associated with raw material import dependence, international price volatility, and competition from imports. Its ability to maintain cost efficiency, ensure consistent product quality, and potentially expand into new applications will be crucial for navigating these challenges and sustaining growth. The high promoter holding suggests commitment, but the company's future performance will largely depend on its execution capabilities in a competitive and commodity-influenced market.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 45 | 50 | 38 | 38 | 50 | 54 | 58 | 41 | 63 | 70 |
| Other Income | 3 | 3 | 4 | 4 | 4 | 3 | 4 | 4 | 5 | 3 |
| Total Income | 49 | 53 | 42 | 42 | 54 | 57 | 61 | 45 | 68 | 73 |
| Total Expenditure | 34 | 33 | 29 | 27 | 40 | 41 | 47 | 32 | 50 | 51 |
| Operating Profit | 15 | 20 | 14 | 14 | 14 | 15 | 14 | 13 | 17 | 22 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 1 | 0 |
| Profit Before Tax | 14 | 19 | 13 | 14 | 13 | 14 | 23 | 12 | 17 | 22 |
| Provision for Tax | 3 | 5 | 4 | 5 | 3 | 4 | 6 | 3 | 3 | 6 |
| Profit After Tax | 11 | 14 | 9 | 9 | 10 | 10 | 16 | 9 | 15 | 16 |
| Adjustments | -0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | -0 |
| Profit After Adjustments | 11 | 14 | 9 | 9 | 10 | 10 | 16 | 9 | 15 | 16 |
| Adjusted Earnings Per Share | 3.6 | 4.4 | 2.9 | 2.8 | 3.2 | 3.2 | 5.1 | 2.9 | 4.5 | 5.1 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 70 | 67 | 101 | 128 | 115 | 144 | 176 | 225 | 191 | 175 | 215 | 232 |
| Other Income | 3 | 3 | 4 | 6 | 6 | 4 | 3 | 7 | 12 | 16 | 15 | 16 |
| Total Income | 72 | 70 | 105 | 134 | 121 | 148 | 179 | 232 | 203 | 191 | 231 | 247 |
| Total Expenditure | 57 | 56 | 86 | 108 | 97 | 100 | 128 | 163 | 149 | 129 | 171 | 180 |
| Operating Profit | 15 | 13 | 19 | 26 | 24 | 48 | 51 | 69 | 55 | 61 | 60 | 66 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 10 | 10 |
| Profit Before Tax | 14 | 12 | 17 | 24 | 23 | 47 | 50 | 69 | 52 | 59 | 67 | 74 |
| Provision for Tax | 4 | 3 | 7 | 7 | 5 | 12 | 14 | 18 | 13 | 16 | 16 | 18 |
| Profit After Tax | 9 | 8 | 11 | 17 | 18 | 34 | 36 | 51 | 39 | 43 | 50 | 56 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 3 | 3 | 4 | 0 |
| Profit After Adjustments | 9 | 8 | 11 | 17 | 18 | 35 | 38 | 51 | 42 | 45 | 54 | 56 |
| Adjusted Earnings Per Share | 2.9 | 2.5 | 3.3 | 5.4 | 5.5 | 10.9 | 11.7 | 15.9 | 13 | 14.1 | 16.9 | 17.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 23% | -2% | 8% | 12% |
| Operating Profit CAGR | -2% | -5% | 5% | 15% |
| PAT CAGR | 16% | -1% | 8% | 19% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 83% | 41% | 22% | 31% |
| ROE Average | 14% | 14% | 17% | 15% |
| ROCE Average | 18% | 19% | 22% | 21% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 87 | 95 | 105 | 121 | 138 | 173 | 207 | 255 | 293 | 335 | 387 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
| Total Current Liabilities | 7 | 8 | 10 | 9 | 8 | 16 | 13 | 18 | 15 | 18 | 16 |
| Total Liabilities | 97 | 106 | 117 | 132 | 149 | 190 | 222 | 275 | 311 | 357 | 405 |
| Fixed Assets | 21 | 22 | 20 | 19 | 15 | 14 | 13 | 16 | 19 | 21 | 9 |
| Other Non-Current Assets | 42 | 44 | 42 | 41 | 54 | 95 | 87 | 91 | 91 | 181 | 71 |
| Total Current Assets | 34 | 40 | 55 | 72 | 80 | 81 | 121 | 168 | 201 | 154 | 324 |
| Total Assets | 97 | 106 | 117 | 132 | 149 | 190 | 222 | 275 | 311 | 357 | 405 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 16 | 4 | 0 | 5 | 3 | 41 | 2 | 36 | 85 | 121 | 7 |
| Cash Flow from Operating Activities | 18 | 21 | 1 | 15 | 13 | 16 | 11 | 60 | 70 | -104 | 87 |
| Cash Flow from Investing Activities | -26 | -24 | 5 | -16 | 26 | -54 | 26 | -8 | -30 | -7 | -77 |
| Cash Flow from Financing Activities | -4 | -1 | -2 | -1 | -1 | -1 | -3 | -3 | -3 | -3 | -3 |
| Net Cash Inflow / Outflow | -12 | -4 | 5 | -2 | 38 | -39 | 34 | 49 | 36 | -115 | 7 |
| Closing Cash & Cash Equivalent | 4 | 0 | 5 | 3 | 41 | 2 | 36 | 85 | 121 | 7 | 14 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.88 | 2.52 | 3.28 | 5.44 | 5.46 | 10.94 | 11.7 | 15.93 | 12.95 | 14.1 | 16.94 |
| CEPS(Rs) | 3.27 | 2.98 | 3.73 | 5.88 | 5.89 | 11.01 | 11.66 | 16.28 | 12.86 | 14.07 | 16.65 |
| DPS(Rs) | 0.15 | 0.15 | 0.15 | 0.15 | 0.2 | 1 | 1 | 1 | 1 | 1 | 40 |
| Book NAV/Share(Rs) | 27.14 | 29.47 | 32.58 | 37.83 | 43.11 | 53.85 | 64.55 | 79.48 | 91.43 | 104.53 | 120.47 |
| Core EBITDA Margin(%) | 16 | 13.67 | 14.23 | 15.65 | 16.22 | 30.57 | 27.24 | 27.54 | 22.36 | 26.19 | 20.5 |
| EBIT Margin(%) | 18.04 | 15.74 | 17.1 | 18.85 | 19.88 | 32.35 | 28.48 | 30.69 | 27.32 | 33.58 | 30.91 |
| Pre Tax Margin(%) | 17.55 | 15.45 | 16.97 | 18.79 | 19.83 | 32.29 | 28.45 | 30.63 | 27.3 | 33.47 | 30.87 |
| PAT Margin (%) | 11.88 | 10.8 | 10.26 | 13.6 | 15.2 | 23.77 | 20.7 | 22.52 | 20.37 | 24.25 | 23.33 |
| Cash Profit Margin (%) | 13.5 | 12.76 | 11.65 | 14.69 | 16.4 | 24.51 | 21.29 | 23.21 | 21.57 | 25.76 | 24.8 |
| ROA(%) | 9.77 | 7.98 | 9.48 | 14.02 | 12.46 | 20.23 | 17.67 | 20.4 | 13.29 | 12.73 | 13.2 |
| ROE(%) | 11.15 | 8.9 | 10.58 | 15.45 | 13.48 | 22.02 | 19.14 | 21.94 | 14.21 | 13.52 | 13.92 |
| ROCE(%) | 16.24 | 12.72 | 17.51 | 21.41 | 17.64 | 29.98 | 26.34 | 29.89 | 19.06 | 18.72 | 18.44 |
| Receivable days | 27.4 | 26.44 | 24.93 | 25.9 | 27.68 | 21.34 | 19.51 | 18.49 | 25.18 | 30.61 | 22.16 |
| Inventory Days | 127.22 | 73.55 | 31.33 | 30.85 | 34.86 | 50.81 | 98.48 | 99.67 | 76.57 | 72.32 | 66.83 |
| Payable days | 40.87 | 36.08 | 20.57 | 11.61 | 12.93 | 24.05 | 24 | 13.79 | 12.56 | 20.2 | 13.71 |
| PER(x) | 10.3 | 11.46 | 15.82 | 7.7 | 2.84 | 5.98 | 12.25 | 6.4 | 12.46 | 12.05 | 14.31 |
| Price/Book(x) | 1.09 | 0.98 | 1.59 | 1.11 | 0.36 | 1.22 | 2.22 | 1.28 | 1.77 | 1.62 | 2.01 |
| Dividend Yield(%) | 0.51 | 0.52 | 0.29 | 0.36 | 1.29 | 1.53 | 0.7 | 0.98 | 0.62 | 0.59 | 16.51 |
| EV/Net Sales(x) | 1.33 | 1.4 | 1.6 | 1.03 | 0.07 | 1.44 | 2.41 | 1.07 | 2.07 | 3.07 | 3.55 |
| EV/Core EBITDA(x) | 6.09 | 7.06 | 8.52 | 5.14 | 0.35 | 4.35 | 8.29 | 3.49 | 7.26 | 8.75 | 12.82 |
| Net Sales Growth(%) | -20.39 | -4.32 | 51.46 | 27.22 | -10.2 | 25.07 | 21.9 | 28.09 | -15.01 | -8.39 | 22.93 |
| EBIT Growth(%) | -31.71 | -15.88 | 48.93 | 37.81 | -5.3 | 103.58 | 7.31 | 38.05 | -24.35 | 12.6 | 13.15 |
| PAT Growth(%) | -31.92 | -12.39 | 30.27 | 65.71 | 0.34 | 95.61 | 6.17 | 39.38 | -23.11 | 9.05 | 18.27 |
| EPS Growth(%) | -29.56 | -12.39 | 30.27 | 65.71 | 0.34 | 100.49 | 6.95 | 36.09 | -18.67 | 8.82 | 20.18 |
| Debt/Equity(x) | 0.03 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 4.79 | 4.92 | 5.47 | 8.18 | 9.46 | 5.18 | 9.48 | 9.56 | 13.2 | 8.68 | 20.85 |
| Quick Ratio(x) | 1.65 | 3.99 | 4.46 | 6.85 | 8.23 | 3.27 | 4.4 | 6.27 | 11.74 | 6.04 | 18.8 |
| Interest Cover(x) | 36.84 | 54.14 | 133.88 | 306.97 | 398.38 | 513.04 | 846.78 | 517.11 | 1886.68 | 317.92 | 969.25 |
| Total Debt/Mcap(x) | 0.02 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 50.8 | 50.8 | 50.8 | 50.8 | 50.8 | 50.8 | 50.8 | 50.8 | 30.8 | 38.41 |
| FII | 0.1 | 0 | 0.06 | 0.01 | 0.02 | 0.02 | 0.53 | 0.23 | 0.45 | 0.13 |
| DII | 0 | 0.06 | 0 | 0 | 0.01 | 0.02 | 0.02 | 0.02 | 0.39 | 0.04 |
| Public | 49.1 | 49.14 | 49.14 | 49.2 | 49.17 | 49.16 | 48.66 | 48.96 | 68.37 | 61.42 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 | 0.99 | 1.23 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.01 | 0.01 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 |
| Public | 1.58 | 1.58 | 1.58 | 1.58 | 1.58 | 1.58 | 1.56 | 1.57 | 2.19 | 1.97 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +23% | -2% | +8% | +12% |
| Operating Profit CAGR | -2% | -5% | +5% | +15% |
| PAT CAGR | +16% | -1% | +8% | +19% |
| Share Price CAGR | +83% | +41% | +22% | +31% |
| ROE Average | +14% | +14% | +17% | +15% |
| ROCE Average | +18% | +19% | +22% | +21% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 50.8 | 50.8 | 50.8 | 50.8 | 50.8 | 50.8 | 50.8 | 50.8 | 30.8 | 38.41 |
| FII | 0.1 | 0 | 0.06 | 0.01 | 0.02 | 0.02 | 0.53 | 0.23 | 0.45 | 0.13 |
| DII | 0 | 0.06 | 0 | 0 | 0.01 | 0.02 | 0.02 | 0.02 | 0.39 | 0.04 |
| Public | 49.1 | 49.14 | 49.14 | 49.2 | 49.17 | 49.16 | 48.66 | 48.96 | 68.37 | 61.42 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 | 0.99 | 1.23 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.01 | 0.01 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 |
| Public | 1.58 | 1.58 | 1.58 | 1.58 | 1.58 | 1.58 | 1.56 | 1.57 | 2.19 | 1.97 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.